Saturday, September 22, 2007

The FDA Reich

The Food & Drug Administration's (FDA) march towards total control and domination continues. Now they're putting "legacy" drugs under new controls. These drugs have been used for years, in many cases prior to the FDA being created in 1962, but now the FDA is demanding they be subjected to full (and costly) FDA review.

FDA reviews can cost between $5 million and $10 million even for a legacy drug and since they're manufactured by small to medium companies who don't have that kind of money to invest, these drugs will either disappear or have new, higher costs as a direct result of FDA red tape.

The FDA admits it is being "aggressive" and promises to become even more so in the future so hold on to your wallet. This move only benefits the big drug companies who have the money and practice to go through the FDA approval process.

Meanwhile I notice how the FDA is going soft on consumer drug advertising. The U.S. is one of only two countries in the world that even allow it and thanks to the just-passed FDA bill the attempt to tone down and retrict ads has been killed. The advertising, media and drug industries worked together to gut legislative attempts to kill their current cash cow. Drug companies spend over $5 Billion in advertising to consumers, 55% on TV.

And who's representing the health and well-being of Americans?

No comments: